Presenter: John Ludlow, PhD, Senior Director Process Research & Assay Development, Tengion, Winston-Salem, North Carolina
Dr. Ludlow has been with Tengion since 2005. After spending 10 years conducting tumor suppressor research at the University of Rochester (NY), Dr. Ludlow went on to become Director of the Cell Therapy Program for Incara Pharmaceuticals, Senior Director of the Cell Therapy Program for Vesta Therapeutics, and is currently Senior Director of Process Research and Assay Development at Tengion. He has developed and managed research and pre-clinical programs for cell and tissue engineered products, initiated clinical trial sites, and has worked closely with regulatory agencies to ensure approval of the company’s products. Dr. Ludlow has also developed internship programs at academic institutions and biotechnology companies to support undergraduate research.